Chairman and CEO of Abbott Laboratories (ABT, Financial) Miles D White sells 172,704 shares of ABT on 12/22/2009 at an average price of $54.21 a share.
Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years. Abbott Laboratories has a market cap of $83.66 billion; its shares were traded at around $54.09 with a P/E ratio of 15 and P/S ratio of 2.8. The dividend yield of Abbott Laboratories stocks is 3%. Abbott Laboratories had an annual average earning growth of 4.4% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 3.5-star.
ABT is in the portfolios of Robert Bruce of Bruce & Co., Inc., Edward Owens of Vanguard Health Care Fund, Diamond Hill Capital of Diamond Hill Capital Management Inc, Jeremy Grantham of GMO LLC, Tom Russo of Gardner Russo & Gardner, John Buckingham of Al Frank Asset Management, Inc., Stanley Druckenmiller of Duquesne Capital Management, LLC, Westport Asset Management, Bill Frels of MAIRS & POWER INC, Bruce Kovner of Caxton Associates, Tom Gayner of Markel Gayner Asset Management Corp, Murray Stahl of Horizon Asset Management, George Soros of Soros Fund Management LLC, Dodge & Cox, Kenneth Fisher of Fisher Asset Management, LLC.
Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years. Abbott Laboratories has a market cap of $83.66 billion; its shares were traded at around $54.09 with a P/E ratio of 15 and P/S ratio of 2.8. The dividend yield of Abbott Laboratories stocks is 3%. Abbott Laboratories had an annual average earning growth of 4.4% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 3.5-star.
ABT is in the portfolios of Robert Bruce of Bruce & Co., Inc., Edward Owens of Vanguard Health Care Fund, Diamond Hill Capital of Diamond Hill Capital Management Inc, Jeremy Grantham of GMO LLC, Tom Russo of Gardner Russo & Gardner, John Buckingham of Al Frank Asset Management, Inc., Stanley Druckenmiller of Duquesne Capital Management, LLC, Westport Asset Management, Bill Frels of MAIRS & POWER INC, Bruce Kovner of Caxton Associates, Tom Gayner of Markel Gayner Asset Management Corp, Murray Stahl of Horizon Asset Management, George Soros of Soros Fund Management LLC, Dodge & Cox, Kenneth Fisher of Fisher Asset Management, LLC.
Directors and Officers Recent Trades:
- Sell:: Senior Vice President Thomas F Chen sold 7,800 shares of ABT stock on 12/18/2009 at the average price of 53.71, the price of the stock has increased by 0.71% since.
- Sell:: Senior Vice President Thomas F Chen sold 5,000 shares of ABT stock on 12/10/2009 at the average price of 53.8, the price of the stock has increased by 0.54% since.
- Sell:: Senior Vice President Donald V Jr Patton sold 9,875 shares of ABT stock on 12/10/2009 at the average price of 54.01, the price of the stock has increased by 0.15% since.
- Sell:: Executive Vice President Holger A Liepmann sold 3,865 shares of ABT stock on 12/10/2009 at the average price of 54.25, the price of the stock has decreased by 0.29% since.
- Sell:: Executive Vice President Holger A Liepmann sold 100 shares of ABT stock on 12/07/2009 at the average price of 54.25, the price of the stock has decreased by 0.29% since.
